These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37338457)

  • 1. Integrated Cascade Nanozymes with Antisenescence Activities for Atherosclerosis Therapy.
    Liu W; Zhang Y; Wei G; Zhang M; Li T; Liu Q; Zhou Z; Du Y; Wei H
    Angew Chem Int Ed Engl; 2023 Aug; 62(33):e202304465. PubMed ID: 37338457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis.
    Pham LM; Kim EC; Ou W; Phung CD; Nguyen TT; Pham TT; Poudel K; Gautam M; Nguyen HT; Jeong JH; Yong CS; Park SY; Kim JR; Kim JO
    Biomaterials; 2021 Feb; 269():120677. PubMed ID: 33503557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Metal-Free Nanozyme for Targeted Imaging and Inhibition of Atherosclerosis via Macrophage Autophagy Activation to Prevent Vulnerable Plaque Formation and Rupture.
    Wang L; Zhang X; Zhang H; Wang X; Ren X; Bian W; Shi C; Wang J; Li L; Zhang R; Zhang H
    ACS Appl Mater Interfaces; 2024 Oct; 16(39):51944-51956. PubMed ID: 39287614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis.
    He H; Han Q; Wang S; Long M; Zhang M; Li Y; Zhang Y; Gu N
    ACS Nano; 2023 Aug; 17(15):14555-14571. PubMed ID: 37350440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway.
    Jiang W; Geng H; Lv X; Ma J; Liu F; Lin P; Yan C
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1129-1145. PubMed ID: 32557012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganoderma lucidum triterpenoids and polysaccharides attenuate atherosclerotic plaque in high-fat diet rabbits.
    Li Y; Tang J; Gao H; Xu Y; Han Y; Shang H; Lu Y; Qin C
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1929-1938. PubMed ID: 33992512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway.
    Yan W; Li D; Zhou X
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):344-352. PubMed ID: 27998006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein disulfide-isomerase A3 knockdown attenuates oxidized low-density lipoprotein-induced oxidative stress, inflammation and endothelial dysfunction in human umbilical vein endothelial cells by downregulating activating transcription factor 2.
    Jia J; Wang Y; Huang R; Du F; Shen X; Yang Q; Li J
    Bioengineered; 2022 Jan; 13(1):1436-1446. PubMed ID: 34983301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness.
    Yu EPK; Reinhold J; Yu H; Starks L; Uryga AK; Foote K; Finigan A; Figg N; Pung YF; Logan A; Murphy MP; Bennett M
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2322-2332. PubMed ID: 28970293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eNOS-Nitric Oxide System Contributes to a Novel Antiatherogenic Effect of Leonurine via Inflammation Inhibition and Plaque Stabilization.
    Ning K; Wang MJ; Lin G; Zhang YL; Li MY; Yang BF; Chen Y; Huang Y; Li ZM; Huang YJ; Zhu L; Liang K; Yu B; Zhu YZ; Zhu YC
    J Pharmacol Exp Ther; 2020 Jun; 373(3):463-475. PubMed ID: 32238453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis.
    Watanabe T; Sato K
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):889-895. PubMed ID: 32409274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
    Wu N; Li RQ; Li L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.
    Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H
    J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways.
    Qin M; Luo Y; Meng XB; Wang M; Wang HW; Song SY; Ye JX; Pan RL; Yao F; Wu P; Sun GB; Sun XB
    Vascul Pharmacol; 2015 Jul; 70():23-34. PubMed ID: 25849952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOF-derived bimetallic nanozyme to catalyze ROS scavenging for protection of myocardial injury.
    Xiang K; Wu H; Liu Y; Wang S; Li X; Yang B; Zhang Y; Ma L; Lu G; He L; Ni Q; Zhang L
    Theranostics; 2023; 13(8):2721-2733. PubMed ID: 37215581
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia.
    Kojima M; Ozawa N; Mori Y; Takahashi Y; Watanabe-Kominato K; Shirai R; Watanabe R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    Thromb Haemost; 2018 Jan; 118(1):182-194. PubMed ID: 29304538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice.
    Park JG; Ryu SY; Jung IH; Lee YH; Kang KJ; Lee MR; Lee MN; Sonn SK; Lee JH; Lee H; Oh GT; Moon K; Shim H
    Atherosclerosis; 2013 Feb; 226(2):356-63. PubMed ID: 23245509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.